Language

English

Publication Date

5-8-2025

Journal

JCI Insight

DOI

10.1172/jci.insight.187531

PMID

40198126

PMCID

PMC12128997

PubMedCentral® Posted Date

4-8-2025

PubMedCentral® Full Text Version

Post-print

Abstract

Metastatic outgrowth in distant microscopic niches requires sufficient nutrients, including fatty acids (FAs), to support tumor growth and to generate an immunosuppressive tumor microenvironment (TME). However, despite the important role of FAs in metastasis, the regulation of FA supply in metastatic niches has not been defined. In this report, we show that tumor endothelium actively promotes outgrowth and restricts antitumor cytolysis by transferring FAs into developing metastatic tumors. We describe a process of transendothelial FA delivery via endosomes that requires mTORC1 activity. Thus, endothelial cell-specific targeted deletion of Raptor (RptorECKO), a unique component of the mTORC1 complex, significantly reduced metastatic tumor burden that was associated with improved markers of T cell cytotoxicity. Low-dose everolimus that selectively inhibited endothelial mTORC1 improves immune checkpoint responses in metastatic disease models. This work reveals the importance of transendothelial nutrient delivery to the TME, highlighting a future target for therapeutic development.

Keywords

Fatty Acids, Animals, Tumor Microenvironment, Mice, Mechanistic Target of Rapamycin Complex 1, Humans, Neoplasm Metastasis, Endothelial Cells, Regulatory-Associated Protein of mTOR, Cell Line, Tumor, Everolimus, Female

Published Open-Access

yes

Share

COinS
 
 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.